Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
FDA Approves Bausch + Lomb’s Photodynamic Laser
Bausch + Lomb and Modulight Corporation, a biomedical laser company, today announced that the FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment of patients…
Regeneron Wins Patens Case Against Novartis
Regeneron Pharmaceuticals Inc. has won a patent case against Novartis AG in a U.S. court, protecting the company’s drug delivery system for its eye drug Eylea. The US Patent Trial and Appeal Board ruled in favor of Regeneron, stating that…
World’s First And Only Sinusoidal Trifocal Intra Ocular Lens
AcrivaUD Trinova Comes to the Fore with its Four Main Features The world’s first and only sinusoidal trifocal iol Acrivaud trinova used by ophthalmologists in 64 countries across the world to correct cataracts and for refractive lens exchange attracts more…
RCA Acquires Retina Center Northwest
Retina Consultants of America (RCA), a physician management services organization, has added Retina Center Northwest (RCNW) in Washington state,. Financial terms of the deal were not disclosed. With the addition of RCNW, RCA adds to its presence in the Pacific…
High-Tech Contact Lenses May Replace Smart Phones
When Alexander Graham Bell brought us the revolutionary first ever telephone back in 1876, the world was changed forever. Ever since then, telephonic devices have been a mainstay of the modern world; an essential part of our everyday lives. Of…
Sifi and Avanzanite Sign License Agreement
Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries. Sifi will manage all ongoing regulatory activities under the terms of the…
Elios Tech Now Registered in the UK
Elios Vision stated that its Elios technology, which is used to treat glaucoma concurrently with cataract surgery, is officially registered in the United Kingdom. The Elios does not require an implant and is designed to provide long-lasting results that may…
Harrow Now Offering Fortisite Formulations for In-Office Use
Harrow announced the availability of Fortisite (compounded Tobramycin 1.5% + Vancomycin 5%) for in-office use from its FDA-registered and FDA-inspected ImprimisRx 503B outsourcing facility. Fortisite formulations are high-concentration, refrigeration-stable, fortified antibiotic formulations in solution that are patent-pending. According to Harrow,…
RCA Acquires Retina Group of New England
Retina Consultants of America (RCA) announced it has added Retina Group of New England (RGNE) into its network of physicians. With this expansion, RCA will enter its 30th partnership and open operations in Connecticut, expanding its presence to 20 states…
FDA Greenlights Genentech’s Vabysmo | OBN
The FDA has approved Genentech’s Vabysmo (faricimab-svoa) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), marking the first bispecific antibody approved for the eye. Vabysmo is also the first and only FDA-approved injectable eye…